Related Experiment Video
Updated: Aug 13, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Substrate reduction therapy in the infantile form of Tay-Sachs disease
B Bembi1, F Marchetti, V I Guerci
1Unità di Malattie Metaboliche, I.R.C.C.S. Burlo Garofolo, Trieste, Italy. bembi@burlo.trieste.it
Abstract:
Substrate reduction therapy (SRT) with miglustat has been proposed for treatment of some lysosomal storage disorders. Based on the positive experience in Gaucher disease and experimental data in Tay-Sachs (TSD) and Sandhoff animal models, the authors investigated the clinical efficacy of SRT in two patients with infantile TSD. SRT could not arrest the patients' neurologic deterioration. However, a significant drug concentration in CSF as well as macrocephaly prevention were observed.
Related Concept Videos
Antiprotozoal Agents
Inborn Errors of Metabolism
ATP Synthase: Mechanism
Phase II Reactions: Miscellaneous Conjugation Reactions
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
